A Study to Establish a Human Menstrual Blood and Tissue Repository for Research

Overview

About this study

The purpose of this study is to collect human menstrual blood at the time of gynecology visits in order to conduct future studies on the isolation and characterization of human menstrual blood and endometrial stem cells to better individualize treatment for abnormal uterine bleeding (AUB) and study the therapeutic properties of human menstrual-derived Mesenchymal Stem Cells (MSCs).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Female patients will be recruited from the gynecology clinic calendars if they are premenopausal and between the ages of 18-50 years of age.

Exclusion Criteria:

Female patients who are not premenopausal or between the ages of 18-50 years old.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Christopher DeStephano, M.D., M.P.H.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Christopher DeStephano, M.D., M.P.H.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials